Show simple item record

dc.contributor.authorPlazak, Michael E
dc.contributor.authorGale, Stormi E
dc.contributor.authorReed, Brent N
dc.contributor.authorHammad, Sara
dc.contributor.authorTon, Van-Khue
dc.contributor.authorKaczorowski, David J
dc.contributor.authorMadathil, Ronson J
dc.contributor.authorRavichandran, Bharath
dc.date.accessioned2021-04-27T18:14:45Z
dc.date.available2021-04-27T18:14:45Z
dc.date.issued2021-01-26
dc.identifier.urihttp://hdl.handle.net/10713/15517
dc.description.abstractOf the 104 patients included, 48 received no induction, 46 received induction, and 10 underwent perioperative desensitization. No differences were observed in the primary endpoint at 12 mo (90.0% versus 97.9%, P = 0.25 for desensitization versus no-induction; 90.0% versus 100%, P = 0.72 for desensitization versus induction). Rates of acute rejection were lower with induction and desensitization compared with no-induction. There were no significant differences in CAV between the groups. Infectious complications were also similar among the groups (10.0% versus 16.7%, P = 0.62 for desensitization versus no-induction; 10.0% versus 30.4%, P = 0.34 for desensitization versus induction).en_US
dc.description.urihttps://doi.org/10.1097/TXD.0000000000001111en_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Healthen_US
dc.relation.ispartofTransplantation Directen_US
dc.rightsCopyright © 2021 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.en_US
dc.subjectperioperative desensitizationen_US
dc.subject.meshHeart Transplantationen_US
dc.titleClinical Outcomes of Perioperative Desensitization in Heart Transplant Recipientsen_US
dc.typeArticleen_US
dc.identifier.doi10.1097/TXD.0000000000001111
dc.identifier.pmid33521247
dc.source.volume7
dc.source.issue2
dc.source.beginpagee658
dc.source.endpage
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record